Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Biliary Tract Cancer × sintilimab × Clear all

Phase

Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 25 Carcinoma, Hepatocellular 23 Carcinoma, Non-Small-Cell Lung 18 Colorectal Neoplasms 13 Esophageal Squamous Cell Carcinoma 9 Lung Neoplasms 8 Nasopharyngeal Carcinoma 7 Cholangiocarcinoma 6 Squamous Cell Carcinoma of Head and Neck 5 Rectal Neoplasms 5 Pancreatic Neoplasms 4 Neoplasm Metastasis 4 Triple Negative Breast Neoplasms 3 Neoplasms 3 Lymphoma, Extranodal NK-T-Cell 3 Esophageal Neoplasms 3 Colonic Neoplasms 3 Carcinoma, Renal Cell 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Nonsquamous Non-Small Cell Lung Cancer 2 Neuroendocrine Tumors 2 Lymphoma, Large B-Cell, Diffuse 2 Locally Advanced Rectal Cancer 2 Glioblastoma 2 Gastric Adenocarcinoma 2 Colorectal Cancer Metastatic 2 Carcinoma, Neuroendocrine 2 Carcinoma 2

Interventions

lenvatinib 3 tislelizumab 2 toripalimab 1 theasinensin A 1 sitravatinib 1 sintilimab 1 pembrolizumab 1 S 1 (combination) 1 Gemcitabine 1 Folfox protocol 1 Fluorouracil 1 Cryosurgery 1 Cisplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05781074 2023-03-24

CASTLE-08

Fudan University

Phase 2 Unknown

Gastrointestinal

Advanced Biliary Tract Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡